Lv2
124 积分 2026-06-23 加入
Evolution of KRAS molecular glues: from allele-selective to Pan-RAS and protein–protein interaction modulators
23小时前
待确认
Abstract PR-06: Personalized RNA neoantigen vaccines induce long-lived CD8+ T effector cells in pancreatic cancer
14天前
已关闭
Pharmacological Targeting of IRF4 As a Therapeutic Strategy for Multiple Myeloma
20天前
已完结
Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond
24天前
已完结
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma
25天前
已完结
The landscape for therapeutic cancer vaccines
26天前
已完结
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
29天前
已完结
Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights from a Large-Scale Real-World Chinese Cohort
1个月前
已关闭
KRAS: the Achilles’ heel of pancreas cancer biology
1个月前
已完结
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study
1个月前
已完结
皖公网安备34019202002308
